Cargando…
Rapid and sustained remission of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with IL-23p19 antagonist (risankizumab)
Autores principales: | Flora, Akshay, Holland, Richard, Smith, Annika, Frew, John W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255171/ https://www.ncbi.nlm.nih.gov/pubmed/34258349 http://dx.doi.org/10.1016/j.jdcr.2021.05.029 |
Ejemplares similares
-
SAPHO Syndrome: Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis
por: Hagiwara, Kiyofumi, et al.
Publicado: (2017) -
Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis (SAPHO): An Interesting Clinical Syndrome
por: Hussain, Ali, et al.
Publicado: (2020) -
Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO): A Case Report
por: Yousaf, Amman, et al.
Publicado: (2021) -
Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis (SAPHO) Syndrome: Clinical and Therapeutic Aspects
por: Condé, Kaba, et al.
Publicado: (2021) -
Synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) Syndrome with Significant Bilateral Pleural Effusions
por: Hasegawa, Shoichi, et al.
Publicado: (2017)